Xiaolei Zhou
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Pain Management and Opioid Use
Papers in
-
- Lymphoma Diagnosis and Treatment 17
- Genetics 13
- Chronic Lymphocytic Leukemia Research 9
- Genetic and Kidney Cyst Diseases 7
- Co-authors
- Joseph A. JohnstonCatherine B. JohannesRobert H. DworkinTrong Kim LeRobert WestDana DiBenedettiAlicia GilsenanF Coste
- Journals
- Blood (8 papers)Journal of Clinical Oncology (5 papers)Journal of Nanobiotechnology (4 papers)British Journal of Haematology (3 papers)Kidney Medicine (3 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Xiaolei Zhou
81 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Pathology and Forensic Medicine 920
- Anesthesiology and Pain Medicine 238
- Applied Psychology 206
- Pharmacology 562
- Oncology 897
Countries citing papers authored by Xiaolei Zhou
This map shows the geographic impact of Xiaolei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Zhou more than expected).
Fields of papers citing papers by Xiaolei Zhou
This network shows the impact of papers produced by Xiaolei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Zhou. The network helps show where Xiaolei Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2018 | 23 | |
| 11 | 2017 | 5 | |
| 12 | Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study Hit paper breakdown → | 2015 | 509 |
| 13 | 2015 | 50 | |
| 14 | 2012 | 69 | |
| 15 | 2011 | 3 | |
| 16 | 2010 | 8 | |
| 17 | 2009 | 48 | |
| 18 | 2006 | 59 | |
| 19 | 2003 | 117 | |
| 20 | 1991 | 23 |
About Xiaolei Zhou
Xiaolei Zhou is a scholar working on Pathology and Forensic Medicine, Genetics, Hepatology, Transplantation and Oncology, having authored 93 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Genetic and Kidney Cyst Diseases (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (920 citations), Anesthesiology and Pain Medicine (238 citations), Applied Psychology (206 citations), Pharmacology (562 citations) and Oncology (897 citations). Xiaolei Zhou has collaborated with scholars based in United States, China and France. Frequent co-authors include Joseph A. Johnston, Catherine B. Johannes, Robert H. Dworkin, Trong Kim Le, Robert West, Dana DiBenedetti, Alicia Gilsenan, F Coste, James Nonnemaker and Ryan Ziemiecki. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Nanobiotechnology, British Journal of Haematology and Kidney Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.